Key statistics
On Friday, Coherus Oncology Inc (8C5:MUN) closed at 1.82, -12.71% below its 52-week high of 2.09, set on Jan 28, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.82 |
|---|---|
| High | 1.82 |
| Low | 1.82 |
| Bid | 1.78 |
| Offer | 1.83 |
| Previous close | 1.86 |
| Average volume | 14.28k |
|---|---|
| Shares outstanding | 120.87m |
| Free float | 102.69m |
| P/E (TTM) | -- |
| Market cap | 252.62m USD |
| EPS (TTM) | -1.62 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 07:01 GMT.
More ▼
- Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
- Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
- Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
- Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update
- Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
- Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
- Coherus Oncology to Participate in Upcoming Investor Conferences
- Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Coherus Oncology to Participate in Upcoming Investor Conferences
More ▼
